Clinical Trial Update: Ketamine in Refractory Convulsive Status Epilepticus [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating ketamine for refractory convulsive status epilepticus has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Status Epilepticus

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Meyer Children's Hospital IRCCS | Conditions: Status Epilepticus | Phase 3 | Status: TERMINATED